Astria Therapeutics Inc (NAS:ATXS)
$ 9.17 -0.11 (-1.19%) Market Cap: 503.55 Mil Enterprise Value: 235.18 Mil PE Ratio: 0 PB Ratio: 1.85 GF Score: 36/100

Astria Therapeutics Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 13, 2023 / 05:20PM GMT
Release Date Price: $11.94 (+2.31%)
Hartaj Singh
Oppenheimer & Co. Inc. - Analyst

Thank you, as always, to the operators for making this so easy for us. Hi, everybody. We're getting to the second half of our day -- first day here. And we have Astria Therapeutics joining us.

I love the picture on this image. That actually is probably how I think the staff has Astria thinks in the long time. I've gotten to know them since the first day I was at Oppenheimer -- company I covered. This is probably how they think, this figure reaching out for the stars. And hopefully, with their current project, STAR-0215, they will get there.

So Jill, please take it away. We leave about five or 10 minutes for Q&A at the end, Jill.

Jill Milne
Astria Therapeutics, Inc. - Co-Founder, CEO, President & Director

Great. Thank you so much, Hartaj. Happy to be here. During our presentation today, I want to remind you that I'll make statements related to our business based on current and future expectations that may be considered forward-looking statements under applicable securities laws.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot